European biotech and clinical-research figures broadly agree with nine major drugmakers whose chairs signed a letter urging governments to reward new medicines better, but say the fixes go well beyond price.
Tag Archive for: pricing
adobe stock photos - Michael Derrer Fuchs Novartis increased its annual profit in 2025 to USD 17.4 billion and raised its dividend. Towards the end of the year, however, growth weakened markedly, weighed down by copycat products. The group has therefore issued a cautious outlook for 2026. The CEO’s high, bonus-driven remuneration has sparked debate.